Gennari A, Brain E, De Censi A, Nanni O, et al. Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): Pilot study with 18F-Fluoroestradiol (18F-FES) CT/PET. Ann Oncol 2024 Feb 27:S0923-7534(24)00057-7. doi: 10.1016/j.annonc.2024.
PMID: 38423389